Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice

Rationale: Multiple biological mechanisms contribute to the efficacy of cardiac cell therapy. Most prominent among these are direct heart muscle and blood vessel regeneration from transplanted cells, as opposed to paracrine enhancement of tissue preservation and/or recruitment of endogenous repair. Objective: Human cardiac progenitor cells, cultured as cardiospheres (CSps) or as CSp-derived cells (CDCs), have been shown to be capable of direct cardiac regeneration in vivo. Here we characterized paracrine effects in CDC transplantation and investigated their relative importance versus direct differentiation of surviving transplanted cells. Methods and Results: In vitro, many growth factors were found in media conditioned by human adult CSps and CDCs; CDC-conditioned media exerted antiapoptotic effects on neonatal rat ventricular myocytes, and proangiogenic effects on human umbilical vein endothelial cells. In vivo, human CDCs secreted vascular endothelial growth factor, hepatocyte growth factor, and insulin-like growth factor 1 when transplanted into the same SCID mouse model of acute myocardial infarction where they were previously shown to improve function and to produce tissue regeneration. Injection of CDCs in the peri-infarct zone increased the expression of Akt, decreased apoptotic rate and caspase 3 level, and increased capillary density, indicating overall higher tissue resilience. Based on the number of human-specific cells relative to overall increases in capillary density and myocardial viability, direct differentiation quantitatively accounted for 20% to 50% of the observed effects. Conclusions: Together with their spontaneous commitment to cardiac and angiogenic differentiation, transplanted CDCs serve as “role models,” recruiting endogenous regeneration and improving tissue resistance to ischemic stress. The contribution of the role model effect rivals or exceeds that of direct regeneration.

[1]  E. Fiumana,et al.  Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function , 2008, Circulation research.

[2]  E. Marbán,et al.  Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. , 2008, Heart rhythm.

[3]  G. Woude,et al.  Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor , 2005, Oncogene.

[4]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[5]  J. M. Wyss,et al.  The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure. , 2004, Current pharmaceutical design.

[6]  A. Rosenzweig Cardiac cell therapy--mixed results from mixed cells. , 2006, The New England journal of medicine.

[7]  Chae-Ryon Kong,et al.  Functional reentry in cultured monolayers of neonatal rat cardiac cells. , 2003, American journal of physiology. Heart and circulatory physiology.

[8]  Qi Fu,et al.  Hemodynamics of orthostatic intolerance: implications for gender differences. , 2004, American journal of physiology. Heart and circulatory physiology.

[9]  H. Haider,et al.  Therapeutic angiogenesis. Devising new strategies based on past experiences. , 2004, Basic research in cardiology.

[10]  Y. Yoon,et al.  Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart , 2007, The Journal of experimental medicine.

[11]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[13]  Stefanie Dimmeler,et al.  Cell-Based Therapy of Myocardial Infarction , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Song-Jung Kim,et al.  Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway. , 2008, American journal of physiology. Heart and circulatory physiology.

[15]  Ying Zhang,et al.  Cellular Cardiomyoplasty: Improvement of Left Ventricular Function Correlates with the Release of Cardioactive Cytokines , 2007, Stem cells.

[16]  Mei-jue Chen,et al.  Multiorgan engraftment and differentiation of human cord blood CD34+Lin− cells in goats assessed by gene expression profiling , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Richard T. Lee,et al.  Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Zentilin,et al.  Adeno-Associated Virus-Mediated Transduction of VEGF165 Improves Cardiac Tissue Viability and Functional Recovery After Permanent Coronary Occlusion in Conscious Dogs , 2006, Circulation research.

[19]  Q. Li,et al.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. , 1997, The Journal of clinical investigation.

[20]  E. Marbán,et al.  Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue , 2009, PloS one.

[21]  H. Haider,et al.  Therapeutic angiogenesis , 2004, Basic Research in Cardiology.

[22]  J. Isner Myocardial gene therapy , 2002, Nature.

[23]  J. Isner,et al.  Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. , 1997, The Annals of thoracic surgery.

[24]  F. Welt,et al.  Cell therapy for acute myocardial infarction: curb your enthusiasm? , 2006, Circulation.

[25]  Long Yang,et al.  Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis. , 2008, Archives of medical research.

[26]  E. Marbán,et al.  Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations. , 2008, Heart rhythm.

[27]  Tetsuo Sasano,et al.  Engraftment, Differentiation, and Functional Benefits of Autologous Cardiosphere-Derived Cells in Porcine Ischemic Cardiomyopathy , 2009, Circulation.

[28]  G. Hasenfuss,et al.  Do stem cells in the heart truly differentiate into cardiomyocytes? , 2007, Journal of molecular and cellular cardiology.

[29]  K. Matsumoto,et al.  A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. , 2001, Cardiovascular research.

[30]  Pauline Chu,et al.  Imaging survival and function of transplanted cardiac resident stem cells. , 2009, Journal of the American College of Cardiology.

[31]  H. Matsubara,et al.  Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. , 2008, Journal of the American College of Cardiology.

[32]  D. Yellon,et al.  Cardioprotective growth factors. , 2009, Cardiovascular research.

[33]  D. Torella,et al.  Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival , 2005, Circulation research.

[34]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[35]  C. Lau,et al.  Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium , 2007, European journal of heart failure.

[36]  F. Sellke,et al.  Gene transfer for angiogenesis in coronary artery disease. , 2001, Annual review of medicine.

[37]  M. Toi,et al.  Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. , 1997, British Journal of Cancer.

[38]  E. Marbán,et al.  Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens , 2007, Circulation.

[39]  R. Wahl,et al.  Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. , 2008, Journal of the American College of Cardiology.

[40]  M. Burnett,et al.  Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.

[41]  I. Burney,et al.  Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. , 2008, World journal of gastroenterology.

[42]  Martin Fussenegger,et al.  Design of artificial myocardial microtissues. , 2004, Tissue engineering.

[43]  Ian E. Alexander,et al.  Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical Coupling , 2005, Circulation.

[44]  G. Roodman,et al.  Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease , 2001 .

[45]  E. Keshet,et al.  Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. , 1994, Cardiovascular research.

[46]  J. Ingwall,et al.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.

[47]  G. Roodman,et al.  Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. , 2001, The Journal of clinical investigation.

[48]  Wuqiang Zhu,et al.  Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 Expression , 2009, Circulation research.

[49]  Jinha M. Park,et al.  Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  M. Ashraf,et al.  Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling , 2006, Circulation research.